This grant, offered by the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program, invites applications from single institutions or consortia to establish research centers. The funding supports integrated clinical and translational research focusing on the underlying mechanisms of onset and progression for a range of allergic and asthmatic conditions. These include asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allergy. The primary objective is to enhance understanding of the pathogenesis of these diseases, thereby laying a crucial foundation for the development of innovative and effective treatments and prevention strategies for improved patient outcomes.
Opportunity ID: 358273
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-AI-24-079 |
Funding Opportunity Title: | Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jan 16, 2025 |
Last Updated Date: | Jan 16, 2025 |
Original Closing Date for Applications: | Jun 13, 2025 |
Current Closing Date for Applications: | Jun 13, 2025 |
Archive Date: | Jul 19, 2025 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Small businesses Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Private institutions of higher education Public housing authorities/Indian housing authorities State governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Native American tribal governments (Federally recognized) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this notice of funding opportunity (NOFO) is to invite applications from single institutions or consortia of institutions to participate in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program. The program will support centers that integrate clinical and translational research to conduct studies on the mechanisms underlying the onset and progression of diseases of interest, including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allergy. The overarching goal of the program is to improve the understanding of the pathogenesis of these conditions and to provide a rational foundation for new, effective treatments and prevention strategies. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-079.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 358273 Full Announcement-RFA-AI-24-079 -> RFA-AI-24-079-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-I | Use for due dates on or after January 25, 2025 | PKG00290170 | May 13, 2025 | Jun 13, 2025 | View |
Package 1
Mandatory forms
358273 RR_SF424_5_0-5.0.pdf
358273 PHS398_CoverPageSupplement_5_0-5.0.pdf
358273 RR_OtherProjectInfo_1_4-1.4.pdf
358273 PerformanceSite_4_0-4.0.pdf
358273 RR_KeyPersonExpanded_4_0-4.0.pdf
358273 PHS398_ResearchPlan_5_0-5.0.pdf
358273 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
358273 PHS_Additional_IndirectCosts_2_0-2.0.pdf
358273 PHS_AssignmentRequestForm_4_0-4.0.pdf